Name | 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole |
Synonyms | RCL T13,695-6 Trityl losartan Trithyl Losartan TRIPHENYL LOSARTAN (2-butyl-4-chloro-1-((2`-(1-trityl-1H-tetrazol-5-yl)biphenyl-1-4-yl)methyl)-1H-i (2-butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-1-4-yl)methyl)-1H-i 2-butyl-4-chloro-1-[2'(2-trityl-2h-tetrazol-5-yl)biphenyl-4-ylmethyl]-1h-imidazol-5-ylmethanol 2-BUTYL-4-CHLORO-1-[2'-(2-TRITYL-2H-TETRAZOLE-5-YL)BIPHENYL-4-YL-METHYL-1H-IMIDAZOLE-5-YL-METHANOL (2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-yl)methanol (2-butyl-4-chloro-1-{[2'-(2-trityl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol (2-Butyl-4-Chloro-1-((2'-(1-Trityl-1h-Tetrazole-5-Yl)Biphenyl-4-Yl)Methyl)-1h-Imidazol-5-Yl)Methanol 2-BUTYL-4-CHLORO-5-(HYDROXY METHYL)-1-[[2'-[(TRIPHENYLMETHYL)TETRAZOLE-5YL]BIPHENYL-4-YL]METHYL] IMIDAZOLE 2-BUTYL-4-CHLORO-1-[[2'-[2-(TRIPHENYLMETHYL)-TETRAZOL-5-YL]-[1,1'-BIPHENYL]-4-YL]METHYL]-1H-IMIDAZOLE-5-METHANOL 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole |
CAS | 133909-99-6 |
EINECS | 412-420-5 |
InChI | InChI=1/C41H37ClN6O/c1-2-3-23-38-43-39(42)37(29-49)47(38)28-30-24-26-31(27-25-30)35-21-13-14-22-36(35)40-44-46-48(45-40)41(32-15-7-4-8-16-32,33-17-9-5-10-18-33)34-19-11-6-12-20-34/h4-22,24-27,49H,2-3,23,28-29H2,1H3 |
Molecular Formula | C41H37ClN6O |
Molar Mass | 665.23 |
Density | 1.22±0.1 g/cm3(Predicted) |
Boling Point | 856.6±75.0 °C(Predicted) |
Flash Point | 471.9°C |
Vapor Presure | 2.96E-31mmHg at 25°C |
pKa | 13.66±0.10(Predicted) |
Storage Condition | 2-8°C |
Refractive Index | 1.656 |
Risk Codes | 53 - May cause long-term adverse effects in the aquatic environment |
Safety Description | 61 - Avoid release to the environment. Refer to special instructions / safety data sheets. |